Cellmid Ltd. appointed Martin Cross as a nonexecutive director of the company.
Cross was previously managing director of Australia's Alphapharm.
Discover more about S&P Global’s offerings
Cellmid adds nonexecutive director
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Cellmid Ltd. appointed Martin Cross as a nonexecutive director of the company.
Cross was previously managing director of Australia's Alphapharm.